Blue Belt Technologies recently announced it has received CE mark for its Stride Unicondylar Knee System.
Indicated for use alongside the company’s proprietary Navio knee system, the Stride system is designed to treat both medial and lateral unicompartmental knee replacement. According to a company press release, the Stride and Navio systems will now be marketed and distributed together in select international markets.
“Receiving CE mark for Stride is an important milestone for Blue Belt as we continue to expand our commercial footprint outside the United States,” Eric Timko, president and CEO of Blue Belt Technologies, said in the release. “We are very pleased with Stride’s early clinical outcomes and, more importantly, the feedback of the physicians utilizing our implant.”